NGEN Latest Press Releases

-- September 9, 2026 --

NervGen to Host Inaugural R&D Day on September 30, 2026 Globe Newswire 7:30 AM

-- August 13, 2026 --

NervGen Reports Second Quarter 2026 Financial Results and Provides Business Updates Globe Newswire 7:30 AM

-- May 26, 2026 --

NervGen Announces Positive Independent, Blinded Biomechanical Gait Analyses Demonstrating Genuine Neural Recovery with NVG-291 in Phase 1b/2a CONNECT SCI Study Globe Newswire 7:15 AM

-- May 21, 2026 --

NervGen Announces Pricing of US$60.0 Million Public Offering of Securities Globe Newswire 11:27 PM

NervGen Announces Proposed Public Offering of Securities Globe Newswire 4:01 PM

-- May 18, 2026 --

NervGen Reports First Quarter 2026 Financial Results and Provides Business Updates Globe Newswire 7:15 AM

-- April 27, 2026 --

NervGen Pharma Strengthens Leadership Team with Appointment of Keith Vendola as Chief Financial Officer Globe Newswire 7:30 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software